Bibliography
- REYNOLDS GP: Schizophrenia - advances in drug ther- apy. Exp. Opin. Invest. Drugs (1997) 6:857–866.
- REYNOLDS GP: What is an atypical antipsychotic? J. Psy-chopharmacol. (1997) 11:195–199.
- TAMMINGA CA, KANE JM: Olanzapine (Zyprexa): char-acteristics of a new antipsychotic. Exp. Opin. Invest. Drugs (1997) 6:1743–1752.
- KANE JM, TAMMINGA CA: Sertindole (Serdolect): pre-clinical and clinical findings of a new atypical antipsy-chotic. Exp. Opin. Invest. Drugs (1997) 6:1729–1741.
- BLAKE T-J, TILLERY CE, REYNOLDS GP: Antipsychotic drug affinities at alpha2 adrenoceptor subtypes in post-mortem human brain. J. Psychopharmacol. (1997) 12. (In Press.)
- PERRAULT G, DEPOORTERE R, MOREL E, SANGER DJ, SCATTON B: Psychopharmacological profile of amisul-pride: an antipsychotic drug with presynaptic D2/133 dopamine receptor antagonist activity and limbic se-lectivity. J. Pharmacol. Exp. Ther. (1997) 280:73–82.
- REYNOLDS GP: The importance of dopamine at recep-tors in the action and development of antipsychotic drugs. Drugs (1996) 51:7–11.
- TANG AH, FRANKLIN SR, HIMES CS, SMITH MW, TEN-BRINK RE: PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J. Pharmacol. Exp. Ther. (1997) 281 :440–447.
- MILLAN MJ, NEWMAN-TANCREDI A, AUDINOT V, DESPAUX N, PEGLION J-L: S18327, a novel phenylimida-zolinone antipsychotic agent I: receptor profile in comparison to haloperidol, clozapine, seroquel and olanzapine. Soc. Neurosci. Abstr. (1997) 23:1930.
- BARTOSZYK GD, GREINER HE, SEYFRIED CA: Pharma-cological profile of ENID 128130: a putative atypical an-tipsychotic with dopamine D2 antagonistic and serotonin 5-HT1A agonistic properties. Soc. Neurosci. Abstr. (1997) 23:530.
- MARQUIS KL, BRENNAN JA, PIESLA MJ et al.: Behavioural pharmacological and neurophysiological profile of a dopamine D2 partial agonist WAY-127312. Soc. Neuro-sci. Abstr. (1997) 23:531.